# US 2016/0355798 A1 · Endonucleases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355798 A1
- Document ID: US20160355798A1
- Status: Published application
- Kind: A1
- Application number: 15/211,843
- Filed: 2016-07-15
- Published: 2016-12-08
- Earliest claimed: 2012-02-17
- Assignees: Biotec Pharmacon ASA
- Applicants: Biotec Pharmacon Asa
- Inventors: Olav LANES; Linda HAVDALEN; Terese SOLSTAD; Marit LORENTZEN; Bjørn ALTERMARK; Ingar LEIROS; Ronny HELLAND
- Web page: https://patentgrep.com/patent/US20160355798A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Y 301/21001: Deoxyribonuclease I (3.1.21.1)
- C12Q 2521/301: Endonuclease
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

The present invention provides an endonuclease I or enzymatically active fragment thereof wherein said endonuclease I has the sequence of SEQ ID No. 4 or a sequence which is at least 70% identical thereto and wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif has been substituted with a residue which is negatively charged as well as nucleic acid molecules encoding these enzymes and methods of removing contaminating polynucleotides from a sample using these enzyme.

## Claims

### Claim 1

A nucleic acid molecule encoding
a) an endonuclease I or enzymatically active fragment thereof, wherein said endonuclease is selected from the group consisting of (i) an endonuclease I having the sequence of SEQ ID NO: 4 and (ii) an endonuclease I having a sequence at least 90% identical to SEQ ID NO: 4, wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif in said endonuclease I or said active fragment has been substituted with a residue which is negatively charged; or
b) encoding a protein comprising said endonuclease I or enzymatically active fragment thereof.

### Claim 2

A method for the isolation and purification of an endonuclease I or enzymatically active fragment thereof, wherein said endonuclease is selected from the group consisting of (i) an endonuclease I having the sequence of SEQ ID NO: 4 and (ii) an endonuclease I having a sequence at least 90% identical to SEQ ID NO: 4, wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif in said endonuclease I or said active fragment has been substituted with a residue which is negatively charged, said method comprising expressing said endonuclease or fragment thereof in a suitable host cell, and subsequently separating the endonuclease from said host cells and/or the media in which said cells have been cultured.

### Claim 3 (depends on 1)

The endonuclease I or enzymatically active fragment thereof of claim 1, wherein said negatively charged residue is selected from the group consisting of glutamic acid, aspartic acid, 4-Fluoro-DL-glutamic acid, γ-Carboxy-DL-glutamic acid and D-2-Aminoadipic acid.

### Claim 4 (depends on 3)

The endonuclease I or enzymatically active fragment thereof of claim 3, wherein said negatively charged residue is glutamic acid.

### Claim 5 (depends on 1)

The endonuclease I or enzymatically active fragment thereof of claim 1, which is derived from Vibrio salmonicida.

### Claim 6 (depends on 1)

The endonuclease I or enzymatically active fragment thereof of claim 1, which is at least 95% inactivated when incubated for 30 minutes at 50° C. in the presence of 0.5 mM TCEP and residual activity is assessed in the presence of 0.5 mM TCEP.

### Claim 7 (depends on 1)

The endonuclease I or enzymatically active fragment thereof of claim 1, which, at a concentration of 0.5 M sodium chloride, has a catalytic activity that is no less than 60% of the catalytic activity exhibited by said endonuclease I or enzymatically active fragment at its optimum salt concentration.

### Claim 8 (depends on 2)

The method of claim 2, wherein said negatively charged residue is selected from the group consisting of glutamic acid, aspartic acid, 4-Fluoro-DL-glutamic acid, γ-Carboxy-DL-glutamic acid and D-2-Aminoadipic acid.

### Claim 9 (depends on 8)

The method of claim 8, wherein said negatively charged residue is glutamic acid.

### Claim 10 (depends on 2)

The method of claim 2, wherein the endonuclease I or enzymatically active fragment thereof is derived from Vibrio salmonicida.

### Claim 11 (depends on 2)

The method of claim 2, wherein the endonuclease I or enzymatically active fragment thereof is at least 95% inactivated when incubated for 30 minutes at 50° C. in the presence of 0.5 mM TCEP and residual activity is assessed in the presence of 0.5 mM TCEP.

### Claim 12 (depends on 2)

The method of claim 2, wherein the endonuclease I or enzymatically active fragment, which, at a concentration of 0.5 M sodium chloride, has a catalytic activity that is no less than 60% of the catalytic activity exhibited by said endonuclease I or enzymatically active fragment at its optimum salt concentration.
